Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs.
作者信息
Prevots D Rebecca, Loddenkemper Robert, Sotgiu Giovanni, Migliori Giovanni Battista
机构信息
Epidemiology Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
German Central Committee against Tuberculosis, Berlin, Germany.
出版信息
Eur Respir J. 2017 Apr 26;49(4). doi: 10.1183/13993003.00374-2017. Print 2017 Apr.
Abstract
摘要
相似文献
1
Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs.非结核分枝杆菌肺病：负担日益加重且成本高昂。
Eur Respir J. 2017 Apr 26;49(4). doi: 10.1183/13993003.00374-2017. Print 2017 Apr.
2
Antibiotic treatment for nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病的抗生素治疗
Expert Rev Respir Med. 2016;10(5):557-68. doi: 10.1586/17476348.2016.1165611. Epub 2016 Mar 30.
3
Nontuberculous Mycobacteria: Epidemiology and the Impact on Pulmonary and Cardiac Disease.非结核分枝杆菌：流行病学及其对肺部和心脏疾病的影响。
Thorac Surg Clin. 2019 Feb;29(1):59-64. doi: 10.1016/j.thorsurg.2018.09.006.
4
Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020.加拿大安大略省非结核分枝杆菌肺病，2020 年。
Emerg Infect Dis. 2023 Jul;29(7):1415-1419. doi: 10.3201/eid2907.230216.
5
Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.非结核分枝杆菌肺病的医学管理
Thorac Surg Clin. 2019 Feb;29(1):65-76. doi: 10.1016/j.thorsurg.2018.09.001.
6
Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial Series.非结核分枝杆菌肺病：临床流行病学特征、危险因素及诊断：非结核分枝杆菌系列研究
Chest. 2022 Mar;161(3):637-646. doi: 10.1016/j.chest.2021.10.003. Epub 2021 Oct 8.
7
Serial sputum induction in nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病的系列痰液诱导
Eur Respir J. 2020 Jun 11;55(6). doi: 10.1183/13993003.02196-2019. Print 2020 Jun.
8
Nontuberculous Mycobacterial Infections.非结核分枝杆菌感染。
Radiol Clin North Am. 2022 May;60(3):399-408. doi: 10.1016/j.rcl.2022.01.012.
9
Comparison of chest computed tomography findings in nontuberculous mycobacterial diseases and Mycobacterium tuberculosis lung disease.非结核分枝杆菌病与肺结核病胸部计算机断层扫描结果的比较。
Respir Investig. 2020 May;58(3):134-136. doi: 10.1016/j.resinv.2020.02.001. Epub 2020 Mar 13.
10
Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review.非结核分枝杆菌性肺病的全球流行病学：综述。
Clin Chest Med. 2023 Dec;44(4):675-721. doi: 10.1016/j.ccm.2023.08.012. Epub 2023 Sep 21.
引用本文的文献
1
Nontuberculous mycobacterial pulmonary disease presenting as bronchiolitis pattern on CT without cavity or bronchiectasis.非结核分枝杆菌肺病 CT 表现为无空洞或支气管扩张的细支气管炎模式。
BMC Pulm Med. 2024 Sep 2;24(1):432. doi: 10.1186/s12890-024-03223-2.
2
Supporting Patients with Nontuberculous Mycobacterial Pulmonary Disease: Ensuring Best Practice in UK Healthcare Settings.支持非结核分枝杆菌肺病患者：确保英国医疗环境中的最佳实践。
Pharmacy (Basel). 2024 Aug 21;12(4):126. doi: 10.3390/pharmacy12040126.
3
Source-to-tap investigation of the occurrence of nontuberculous mycobacteria in a full-scale chloraminated drinking water system.从水源到龙头的调查研究，以确定在大规模加氯消毒饮用水系统中，非结核分枝杆菌的发生情况。
Appl Environ Microbiol. 2024 Sep 18;90(9):e0060924. doi: 10.1128/aem.00609-24. Epub 2024 Aug 7.
4
Discovery of urinary biosignatures for tuberculosis and nontuberculous mycobacteria classification using metabolomics and machine learning.采用代谢组学和机器学习技术发现用于结核病和非结核分枝杆菌分类的尿液生物标志物。
Sci Rep. 2024 Jul 3;14(1):15312. doi: 10.1038/s41598-024-66113-x.
5
Detection of Mtb and NTM: preclinical validation of a new asymmetric PCR-binary deoxyribozyme sensor assay.结核分枝杆菌和非结核分枝杆菌的检测：新型不对称 PCR-双脱氧核酶传感器检测方法的临床前验证。
Microbiol Spectr. 2024 Jun 4;12(6):e0350623. doi: 10.1128/spectrum.03506-23. Epub 2024 Apr 23.
6
In vitro and ex vivo activity of the fluoroquinolone DC-159a against mycobacteria.氟喹诺酮 DC-159a 对分枝杆菌的体外和体内活性。
J Antibiot (Tokyo). 2024 May;77(5):306-314. doi: 10.1038/s41429-024-00709-3. Epub 2024 Mar 4.
7
E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection.E3 泛素连接酶 CBLB 调控非结核分枝杆菌感染期间的固有免疫反应和细菌播散。
J Leukoc Biol. 2024 May 29;115(6):1118-1130. doi: 10.1093/jleuko/qiae019.
8
Development of prevalence and incidence of non-tuberculous mycobacteria in German laboratories from 2016 to 2020.2016 年至 2020 年德国实验室中非结核分枝杆菌的流行率和发病率的发展。
Emerg Microbes Infect. 2023 Dec;12(2):2276342. doi: 10.1080/22221751.2023.2276342. Epub 2023 Dec 6.
9
Trends from the Last Decade with Nontuberculous Mycobacteria Lung Disease (NTM-LD): Clinicians' Perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland.过去十年非结核分枝杆菌肺病（NTM-LD）的趋势：波兰比得哥什肺病区域中心临床医生的观点
Pathogens. 2023 Jul 28;12(8):988. doi: 10.3390/pathogens12080988.
10
Diagnosis of Non-Tuberculous Mycobacterial Pulmonary Disease by Metagenomic Next-Generation Sequencing on Bronchoalveolar Lavage Fluid.基于支气管肺泡灌洗液宏基因组二代测序技术诊断非结核分枝杆菌肺病
Infect Drug Resist. 2023 Jun 26;16:4137-4145. doi: 10.2147/IDR.S417088. eCollection 2023.
本文引用的文献
1
Burden of non-tuberculous mycobacterial pulmonary disease in Germany.德国非结核分枝杆菌肺病的负担。
Eur Respir J. 2017 Apr 26;49(4). doi: 10.1183/13993003.02109-2016. Print 2017 Apr.
2
Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline.耐多药结核病及其他情况：关于贝达喹啉现有证据的最新分析
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.00146-2017. Print 2017 Mar.
3
Bedaquiline as a potential agent in the treatment of and infections.贝达喹啉作为治疗[具体感染类型]感染的潜在药物。 （注：原文中“and”前后的感染类型缺失，所以这里翻译不太完整）
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.01969-2016. Print 2017 Mar.
4
Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.美国夏威夷非结核分枝杆菌肺病和结核病的流行病学
Emerg Infect Dis. 2017 Mar;23(3):439-447. doi: 10.3201/eid2303.161827.
5
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.非结核分枝杆菌肺病患者对管理指南的依从性较差。
Eur Respir J. 2017 Feb 15;49(2). doi: 10.1183/13993003.01855-2016. Print 2017 Feb.
6
Notification of Nontuberculous Mycobacteria: An Australian Perspective.非结核分枝杆菌的通报：澳大利亚视角
Ann Am Thorac Soc. 2017 Mar;14(3):318-323. doi: 10.1513/AnnalsATS.201612-994OI.
7
On the Reportability of Nontuberculous Mycobacterial Disease to Public Health Authorities.非结核分枝杆菌病向公共卫生当局报告的情况
Ann Am Thorac Soc. 2017 Mar;14(3):314-317. doi: 10.1513/AnnalsATS.201610-802PS.
8
Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008-2013.2008 - 2013年五个州非结核分枝杆菌感染患病率上升
Ann Am Thorac Soc. 2016 Dec;13(12):2143-2150. doi: 10.1513/AnnalsATS.201605-353OC.
9
Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan.日本肺部非结核分枝杆菌病的流行病学
Emerg Infect Dis. 2016 Jun;22(6):1116-7. doi: 10.3201/eid2206.151086.
10
Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012.2007年至2012年期间，肺部鸟分枝杆菌复合群是英格兰、威尔士和北爱尔兰非结核分枝杆菌发病率上升的主要驱动因素。
BMC Infect Dis. 2016 May 6;16:195. doi: 10.1186/s12879-016-1521-3.
Zotero 插件